Executive Director, Global Clinical Supply Chain - Oncology

Foster City, California, United States

Apply with AI Apply

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

BiopharmaceuticalIndustries

Requirements

Candidates should possess a Bachelor’s degree in Supply Chain Management, Pharmacy, or a related scientific field, with a Master’s degree being preferred. They should have at least 10 years of experience in clinical supply chain operations, with a strong focus on oncology, and a minimum of 5 years in a leadership role. Demonstrated expertise in global clinical supply planning, inventory management, and distribution is essential, along with a deep understanding of pharmaceutical development processes and regulatory requirements.

Responsibilities

The Executive Director, Global Clinical Supply Chain will be responsible for leading the clinical planning function within a designated therapeutic area, providing subject matter expertise on a diverse portfolio of development programs and different therapeutic modalities. They will collaborate internally with various functions, including Development Operations, Clinical Operations, and Process Development and Manufacturing, to develop strategies, meet project deliverables, solve business problems, and create competitive advantage. This role encompasses end-to-end clinical planning and execution, from protocol design to clinical site distribution and inventory management of clinical supplies worldwide.

Skills

Clinical Supply Chain Management

Oncology

Biopharmaceutical

HIV

Viral Hepatitis

Cancer

Small Molecules

Biologics

Cell Gene Therapy

Protocol Design

Manufacturing

Distribution

Strategic Planning

Cross-functional Collaboration

Leadership

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free